79 results
8-K
EX-99.1
FGEN
FibroGen Inc
26 Feb 24
FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
4:08pm
myelodysplastic syndromes at American Society of Hematology Annual Meeting.
Corporate
Thane Wettig appointed Chief Executive Officer.
Successful execution
8-K
EX-99.1
FGEN
FibroGen Inc
6 Nov 23
FibroGen Reports Third Quarter 2023 Financial Results
4:05pm
for CIA in patients with non-myeloid malignancies in an oral presentation at the European Society for Medical Oncology Congress 2023.
FibroGen and its … Society of Nephrology (ASN) Kidney Week 2023 conference.
Presented preclinical data for the FG-3165 anti-Gal9 antibody program at the Society
CORRESP
nbam0p1w1u7o2 mee08t
16 Dec 21
Correspondence with SEC
12:00am
8-K
EX-99.1
dtgsa62 yeq2lvx1am5q
9 Nov 21
FibroGen Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
qd4q1dh 33
9 Aug 21
FibroGen Reports Second Quarter 2021 Financial Results
4:05pm
8-K
EX-99.1
dtpseqz4 e7x
10 May 21
FibroGen Reports First Quarter 2021 Financial Results
4:07pm